| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ALDER BIOPHARMACEUTICALS INC | 1,000,000 | 32,770,000 | 0.43% | ||
| 52 | QIAGEN NV | 1,000,000 | 27,440,000 | 0.36% | ||
| 53 | ASHLAND GLOBAL HLDGS INC | 232,425 | 26,950,000 | 0.36% | ||
| 54 | ACADIA PHARMACEUTICALS INC COM | 800,000 | 25,448,000 | 0.34% | ||
| 55 | U S SILICA HLDGS INC | 500,000 | 23,280,000 | 0.31% | ||
| 56 | OPHTHOTECH CORP | 300,000 | 13,839,000 | 0.18% | ||
| 57 | KELLOGG CO | 166,500 | 12,899,000 | 0.17% | ||
| 58 | COMSTOCK RES INC | 829,254 | 6,336,000 | 0.08% | ||
| 59 | CAESARS ACQUISITION CO CL A | 129,454 | 1,608,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001443689-16-000022, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
